ANNANDALE CAPITAL, LLC – UroGen Pharma Ltd. Transaction History
ANNANDALE CAPITAL, LLC portfolio value:
$702,000
portfolio value
ANNANDALE CAPITAL, LLC quarter portfolio value change:
+1.59%
quarter
UroGen Pharma Ltd. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 11K | $8.32 | 84.33K | |
| Q2 2022 | share | 0.00% | 0 shares | -44K | $8.19 | 84.33K | |
| Q1 2022 | share | Decrease | -2.23% | -1.92K shares | -85K | $8.71 | 84.33K |
| Q4 2021 | share | 0.00% | 0 shares | -631K | $9.9 | 86.25K | |
| Q3 2021 | share | 0.00% | 0 shares | 134K | $16.82 | 86.25K | |
| Q2 2021 | share | 0.00% | 0 shares | -363K | $15.27 | 86.25K | |
| Q1 2021 | share | 0.00% | 0 shares | 126K | $19.48 | 86.25K | |
| Q4 2020 | share | Increase | 0.00% | 86.25K shares | 1.55M | $18.02 | 86.25K |